Back

Potential for bruton's tyrosine kinase inhibitors as additional antiplatelet agents in acute coronary syndromes

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Coronary artery disease miscellaneous Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Sarah L Ayton

University of Leicester, Leicester (United Kingdom of Great Britain & Northern Ireland)

14 More presentations in this session

Presentation thumbnail
Vascular access devices (VADs), vascular closure devices (VCDs) and hemorrhagic complications - real-life study in our hospital
Mr F. Moniz Mendonca (Funchal, PT)
Abstract Slides
Presentation thumbnail
Gender-related association between traditional risk factors and obstructive coronary artery disease in stable symptomatic patients
Doctor J. Park (Seoul, KR)
Abstract
Presentation thumbnail
The impact of revascularization by elective percutaneous coronary intervention on autonomic modulation assessed by heart rate variability
Doctor M. Abdelnabi (Phoenix, US)
Presentation thumbnail
The impact of thyriod hormones on the prognosis of coronary heart disease patients with subclinical hypothyroidism in SYNTAXII system
Professor R. Huang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Substantial international variation in patterns of investigation for patients with suspected unstable angina - a TRAPID-AMI substudy
Doctor C. Reynard (Manchester, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Coronary artery disease miscellaneous

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources